Atlas Trials

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Clinical trial NCT04481113 · COMPLETED

Trial details

NCT number
NCT04481113
Sponsor
OHSU Knight Cancer Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8HER2 Negative Breast AdenocarcinomaHormone Receptor Positive Breast AdenocarcinomaInvasive Breast CarcinomaMultifocal Breast CarcinomaPrognostic Stage I Breast Cancer AJCC v8
Start date
2021-06-07
Primary completion
2023-10-11
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.